Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

More On HBP.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Helix BioPharma Corp (HBP.TO)

-Toronto
2.13 Up 0.04(1.91%) Aug 28, 1:15PM EDT
Add to Portfolio
Prev Close:2.09
Open:2.00
Bid:2.00
Ask:2.14
1y Target Est:N/A
Beta:-0.311494
Next Earnings Date:N/A
Day's Range:1.95 - 2.13
52wk Range:1.34 - 2.35
Volume:146,900
Avg Vol (3m):15,003
Market Cap:180.31M
P/E (ttm):N/A
EPS (ttm):-0.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the tre... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback